Metraipolis › archive › dc_0287d085e88a

Exploring the mechanism of Kanglixin capsules in the treatment of non-small cell lung cancer based on network pharmacology and molecular docking — Europe PMC PMID:41029040

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41029040
DOI
10.1097/md.0000000000044768
License (as archived)
solo-consultazione
Archived
2026-11-10T05:36:25.865Z
SHA-256 of the archived text
b4dc577de664c0a9472e65dc36ab970dc66bf64aec847d3114c6035e9527d305
Stable URL of this page
https://metraipolis.com/documento/dc_0287d085e88a

How to cite

Exploring the mechanism of Kanglixin capsules in the treatment of non-small cell lung cancer based on network pharmacology and molecular docking — Europe PMC PMID:41029040 — Europe PMC (en), https://europepmc.org/article/MED/41029040 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0287d085e88a (Metraipolis archive dc_0287d085e88a, sha256 b4dc577de664c0a9472e65dc36ab970dc66bf64aec847d3114c6035e9527d305)
BibTeX
@misc{dc0287d085e88a,
  title = {Exploring the mechanism of Kanglixin capsules in the treatment of non-small cell lung cancer based on network pharmacology and molecular docking — Europe PMC PMID:41029040},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41029040},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0287d085e88a; sha256 b4dc577de664c0a9472e65dc36ab970dc66bf64aec847d3114c6035e9527d305},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41029040. Agents can read the archived copy with the MCP tool read_document.